The predictive value of miR-29b-2-5p on the prognosis of cervical cancer and its inhibitory effect on cervical cancer progression

  • 0Department of Internal Medicine, Guangzhou Zengcheng Xintang Hospital, Guangzhou, China.

|

|

Summary

This summary is machine-generated.

MicroRNA miR-29b-2-5p is downregulated in cervical cancer, correlating with poorer prognosis. Overexpressing miR-29b-2-5p suppresses tumor progression, indicating its potential as a therapeutic target for cervical cancer.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • Cervical cancer presents a poor prognosis with increasing mortality.
  • MicroRNAs (miRNAs) play a role in various cancers, including cervical cancer.

Purpose Of The Study

  • To investigate the clinical significance of miR-29b-2-5p in cervical cancer.
  • To explore the role of miR-29b-2-5p in cervical cancer progression.

Main Methods

  • Quantitative polymerase chain reaction (PCR) to analyze miR-29b-2-5p expression in tissues and cells.
  • Kaplan-Meier curves and multivariate Cox regression for prognostic analysis.
  • In vitro cell experiments to assess the impact on proliferation, migration, and invasion.

Main Results

  • miR-29b-2-5p expression was significantly downregulated in cervical cancer tissues and cells.
  • Higher miR-29b-2-5p expression correlated with improved 5-year progression-free survival.
  • miR-29b-2-5p suppressed cervical cancer cell proliferation, migration, and invasion.

Conclusions

  • Downregulated miR-29b-2-5p serves as an independent prognostic factor in cervical cancer.
  • Overexpression of miR-29b-2-5p exhibits tumor-suppressive activity, inhibiting cervical cancer progression.